FXR with SRC1 and GSK826
The structure was published by Akwabi-Ameyaw, A., Bass, J.Y., Caldwell, R.D., et al., Todd, D., Williams, S.P., and Bruce Wisely, G., in 2009 in a paper entitled "FXR agonist activity of conformationally constrained analogs of GW 4064." (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 2.6 Å and deposited in 2009.
The experimental data on which the structure is based was also deposited.
This PDB entry contains a complex of 2 biomacromolecules, namely Bile acid receptor and Nuclear receptor coactivator 1.
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule most likely forms heterodimers.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):
This entry contains 2 unique UniProt proteins: